CD5 and diffuse large B-cell lymphoma: No significant differences in MYC and BCL2 rearrangements were found between CD5+ and CD5-, but more BCL6 rearrangements were detected in CD5- DLBCL (6 of 23, 26.1%, P = 0.048).